美邦股份(605033) - 2022 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2022 was CNY 487,555,601.85, representing a year-on-year increase of 77.56%[5] - The net profit attributable to shareholders for the same period was CNY 91,752,261.05, up 96.99% compared to the previous year[5] - Basic and diluted earnings per share were both CNY 0.68, reflecting a growth of 47.53% year-on-year[6] - The total profit for Q1 2022 was ¥106,934,436.60, up from ¥54,957,683.45 in the same period last year, indicating a growth of 94.3%[20] - The operating profit for Q1 2022 reached ¥106,982,851.88, compared to ¥54,724,946.64 in Q1 2021, reflecting an increase of 95.5%[22] - The net profit attributable to shareholders of the parent company for Q1 2022 was ¥91,752,261.05, compared to ¥46,576,192.23 in Q1 2021, representing an increase of 96.7%[20] Assets and Liabilities - The total assets at the end of the reporting period were CNY 1,446,430,467.04, a decrease of 1.16% from the end of the previous year[6] - Total assets as of March 31, 2022, were ¥1,446,430,467.04, slightly down from ¥1,463,381,113.31 at the end of 2021[16] - Total liabilities decreased to ¥387,725,822.77 from ¥496,428,730.09, a decline of 22%[16] - The company's equity attributable to shareholders increased to ¥1,058,704,644.27 from ¥966,952,383.22, reflecting a growth of 9.5%[16] Cash Flow - The company's cash flow from operating activities was negative at CNY -81,768,900.40, indicating a significant cash outflow[5] - The cash flow from operating activities for Q1 2022 was a net outflow of ¥81,768,900.40, an improvement from a net outflow of ¥126,499,568.84 in Q1 2021[22] - The cash flow from investing activities generated a net inflow of ¥13,871,427.04 in Q1 2022, compared to a net outflow of ¥33,019,410.87 in Q1 2021[23] - The total cash and cash equivalents at the end of Q1 2022 were ¥91,338,101.17, significantly up from ¥19,793,671.70 at the end of Q1 2021[23] Expenses - Total operating costs for Q1 2022 were ¥361,683,622.68, up 71.8% from ¥210,667,507.00 in Q1 2021[18] - Research and development expenses rose by 94.81%, reflecting increased investment in R&D[7] - Research and development expenses for Q1 2022 were ¥25,662,200.89, up from ¥13,173,234.98 in Q1 2021, marking a rise of 94.5%[22] - The company reported a significant increase in sales expenses by 205.31%, attributed to higher sales activities[7] - The company reported a decrease in financial expenses, with interest expenses of ¥151,987.12 in Q1 2022, compared to ¥112,152.77 in Q1 2021, indicating a rise of 35.4%[22] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 14,797[9] Market Strategy - The company is focusing on expanding its market presence and enhancing product development, although detailed strategies were not specified in the report[18]